Latest Breaking News On - நோவோ குழு - Page 4 : comparemela.com

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases - Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB - Developing small molecules to repair neuronal dysfunction and resolve neuroinflammation - Innovative drug discovery platform leveraging insights from novel targets and pathways, resilience to neurodegeneration and all-in-human validation News provided by Share this article Share this article COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/  Muna Therapeutics ( Muna ), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today announced the successful closing of a US$ 73 million (EUR 60 million) Series A financing round. The investor syndicate was co-led by Novo Holdings, Sofinnova Partners, Droia Ventur

New yorkUnited statesFrance generalRegion flamandeCity ofUnited kingdomSan franciscoNoord hollandLuc dochezRita balice gordonIsaac ciechanoverSimon glerupCillian kingHenrijette richterAnders hinsbyMorten graugaard